Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) | MicrobiomeTrials← Back to trialsNCT07756840
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-29Est. Completion: 2029-07-01
Enrollment target: 50 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Recurrent Respiratory Papillomatosis (RRP)
The investigators propose the study titled "Efficacy of booster injection with Gardasil-9 vaccine on intersurgical inter…
Columbus, United StatesEst. completion Apr 1, 2028
Respiratory Tract DiseasesNeoplasmsNeoplasms by Histologic TypeNeoplasms, Glandular and EpithelialNeoplasms, Squamous CellTumor Virus InfectionsInfections
Virus Diseases
DNA Virus Infections
Pathologic Processes
Disease Attributes
Recurrence
Papilloma
Respiratory Tract Infections
Papillomavirus Infections
Background:
Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. …
Bethesda, United StatesEst. completion Jul 31, 2027